CTK8A3536
CAS No. 926228-58-2
CTK8A3536( (2-MORPHOLIN-4-YL-4-PHENYL-1,3-THIAZOL-5-YL)METHANOL )
Catalog No. M22238 CAS No. 926228-58-2
CTK8A3536 is an inhibitor of Androgen receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 177 | Get Quote |
|
| 5MG | 268 | Get Quote |
|
| 10MG | 408 | Get Quote |
|
| 25MG | 672 | Get Quote |
|
| 50MG | 945 | Get Quote |
|
| 100MG | 1278 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCTK8A3536
-
NoteResearch use only, not for human use.
-
Brief DescriptionCTK8A3536 is an inhibitor of Androgen receptor.
-
DescriptionCTK8A3536 is an inhibitor of Androgen receptor.
-
In Vitro——
-
In Vivo——
-
Synonyms(2-MORPHOLIN-4-YL-4-PHENYL-1,3-THIAZOL-5-YL)METHANOL
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
RecptorAndrogen receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number926228-58-2
-
Formula Weight276.35
-
Molecular FormulaC14H16N2O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOCc1[s]c(nc1c2ccccc2)N3CCOCC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
AZD3514
AZD3514 is a potent and oral androgen receptor downregulator with Ki of 2.2 μM and has ability of reducing AR protein expression.Phase 1.
-
Dimethylcurcumin
Dimethylcurcumin (ASC-J9) is an androgen receptor degradation enhancer. It effectively suppresses castration-resistant prostate cancer cell proliferation and invasion.Dimethylcurcumin is able to degrade fAR and AR3 in a dose-dependent manner in various human PCa cells. Dimethylcurcumin can also effectively suppress AR-targeted genes in CWR22Rv1-fARKD cells.
-
N-desmethyl Enzaluta...
Amajor metabolite of Enzalutamide (MDV3100) which is an androgen-receptor (AR) antagonist for treatment of prostate cancer.
Cart
sales@molnova.com